Post hoc analysis shows filgotinib improves health-related quality of life in Japanese ulcerative colitis patients, indicating a sustained benefit over time.
FIL200 treatment was associated with sustained improvements in HRQoL and work productivity over 3 years in Japanese patients with ulcerative colitis, consistent with the overall SELECTION and SELECTIONLTE trial populations.
No takes yet. Share an insight, caveat, or question.
Matsuoka et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: